Development, Characterization, and In Vitro Biological Performance of Amphotericin B and Terbinafine Microemulsions Against Leishmania major-Reference-Cited by-同舟云学术

Development, Characterization, and In Vitro Biological Performance of Amphotericin B and Terbinafine Microemulsions Against Leishmania major

Published:2022-11-03 Issue:12 Volume:79 Page:
ISSN:0343-8651
Container-title:Current Microbiology
language:en
Short-container-title:Curr Microbiol

Author:

Baharvandi Zeynab^ORCID,Salimi Anayatollah^ORCID,Arjmand Reza^ORCID,Jelowdar Ali^ORCID,Rafiei Abdollah^ORCID

Funder

Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Applied Microbiology and Biotechnology,General Medicine,Microbiology

Link

https://link.springer.com/content/pdf/10.1007/s00284-022-03075-1.pdf

Reference48 articles.

1. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J et al (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7(5):e35671. https://doi.org/10.1371/journal.pone.0035671

2. Reithinger R, Dujardin J-C, Louzir H, Pirmez C, Alexander B, Brooker S (2007) Cutaneous leishmaniasis. Lancet Infect Dis 7(9):581–596. https://doi.org/10.1016/S1473-3099(07)70209-8

3. Mishra J, Saxena A, Singh S (2007) Chemotherapy of leishmaniasis: past, present and future. Curr Med Chem 14(10):1153–1169. https://doi.org/10.2174/092986707780362862

4. Farajzadeh S, Esfandiarpour I, Haghdoost AA, Mohammadi S, Mohebbi A, Mohebbi E et al (2015) Comparison between combination therapy of oral terbinafine and cryotherapy versus systemic meglumine antimoniate and cryotherapy in cutaneous leishmaniasis: a randomized clinical trial. Iran J Parasitol 10(1):1–8

5. Berman J (2015) Amphotericin B formulations and other drugs for visceral leishmaniasis. Am J Trop Med Hyg 92(3):471–473. https://doi.org/10.4269/ajtmh.14-0743